Page last updated: 2024-09-05

eslicarbazepine acetate and Visceral Pain

eslicarbazepine acetate has been researched along with Visceral Pain in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Micov, AM; Pecikoza, UB; Stepanović-Petrović, RM; Tomić, MA	1

Other Studies

1 other study(ies) available for eslicarbazepine acetate and Visceral Pain

Article	Year
The Efficacy of Eslicarbazepine Acetate in Models of Trigeminal, Neuropathic, and Visceral Pain: The Involvement of 5-HT1B/1D Serotonergic and CB1/CB2 Cannabinoid Receptors. Anesthesia and analgesia, 2015, Volume: 121, Issue:6 Topics: Animals; Diabetic Neuropathies; Dibenzazepines; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred C57BL; Pain Measurement; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Treatment Outcome; Trigeminal Nerve Diseases; Visceral Pain	2015

Article

Year

The Efficacy of Eslicarbazepine Acetate in Models of Trigeminal, Neuropathic, and Visceral Pain: The Involvement of 5-HT1B/1D Serotonergic and CB1/CB2 Cannabinoid Receptors.

Anesthesia and analgesia, 2015, Volume: 121, Issue:6

Topics: Animals; Diabetic Neuropathies; Dibenzazepines; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred C57BL; Pain Measurement; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Treatment Outcome; Trigeminal Nerve Diseases; Visceral Pain

2015